Bangladesh Measles Outbreak Triggers Emergency Vaccination Campaign Amid Waning Coverage

Overview

Bangladesh is confronting a measles outbreak that began in March 2026, with almost 900 deaths and most casualties among children. A major vaccination campaign is underway, guided by WHO advice to expand dosing and accompanied by vitamin A for affected children. The response also highlights persistent gaps in routine immunization caused by the pandemic and political instability.

• Outbreak linked to years of protection gaps and vaccination coverage sliding to about 87%.
• Emergency vaccination campaign approved for children six months to five years, with extra provisions for younger infants.
• Vaccine hesitancy and social determinants such as poverty and education influence uptake.
• UNICEF, WHO and partners coordinate a nationwide effort to register children and deliver vaccines while supporting vitamin A distribution.

Bangladesh faces a serious measles outbreak

Between March 15 and September 6 2026, Bangladesh reported 92 suspected measles cases per 100 000 population and 11 confirmed measles cases per 100 000, based on a national population of 178 million. The outbreak has already claimed roughly 900 lives, most among young children. The situation underscores the high contagiousness of measles and the need for active, widespread vaccination to slow transmission and prevent severe illness.

Measles transmission and herd immunity

Measles is among the most infectious diseases known; to keep it under control, about 95% of a community must be vaccinated. Even small declines in coverage create pockets of vulnerability that can spark outbreaks when an imported case arrives. The Bangladesh experience shows how gaps accumulated over years lead to large-scale crises when routine immunization stalls.

Drivers of low vaccination coverage

The outbreak is linked to disruption of routine vaccination during the COVID-19 pandemic and ensuing political instability. Bangladesh had hoped to eliminate measles and rubella by 2020, but interruptions left pockets of unprotected children. Vaccine hesitancy is also a factor: during the pandemic, nearly half the population was wary of vaccination, and some parents refused measles rubella jabs. Other social determinants, including poverty, education levels, and antenatal attendance, influence whether children are vaccinated.

Response measures

In March 2026, the vaccine advisory group approved an emergency measles rubella vaccination campaign for children aged six months to five years, with extra provisions for infants six to eight months. WHO recommended giving one additional dose to all children in the target age group during the outbreak, to slow transmission and prevent severe disease. The campaign began in early April in 30 sub‑districts across 18 priority districts, and later extended nationwide. It marked the first national measles campaign since 2020. Alongside vaccination, every child with suspected or confirmed measles received vitamin A. District rapid‑response teams were activated, hospitals added isolation beds, and health authorities issued new guidelines for vaccination supply and patient care. UNICEF, WHO and Gavi supported the government, while Save the Children conducted community awareness and door‑to‑door outreach to encourage vaccination.

Outlook and lessons

Despite the large‑scale campaign, risks remain. If children miss routine booster shots, large gatherings continue, or rumours discourage vaccination, another wave could occur. The Bangladesh case underlines a broader public health challenge: vaccines work, but only when they reach people who need them and when trust and access are ensured. The elimination status of measles and rubella in various regions shows that sustained routine vaccination, robust surveillance, and rapid outbreak response are essential to keeping disease at bay.

Global context

Some countries have eliminated measles and rubella, such as Cabo Verde, Mauritius and Seychelles in sub‑Saharan Africa. In the Americas, elimination was declared in 2016 but was interrupted by outbreaks linked to Venezuela, Brazil and Canada, with elimination status regained in 2024 and then challenged again in 2025. Bangladesh’s outbreak serves as a reminder that even with safe, effective vaccines, maintaining high coverage requires ongoing public trust, reliable vaccine access, and readiness to respond to outbreaks.

Implications for the future

The episode illustrates that vaccines are a powerful public health tool, but their effectiveness depends on sustained coverage, clear communication, and robust health systems that can react swiftly to outbreaks and to rumors that undermine uptake. The Bangladesh experience adds to a global narrative about safeguarding gains in vaccination against the vulnerabilities introduced by crises and misinformation.